From July 1, 2022 to September 30, 2022, the company has repurchased 16,659,900 shares, representing 2.16% for CNY 83.37 million. With this, the company has completed the repurchase of 26,669,910 shares, representing 3.45% for CNY 129.35 million under the buyback announced on May 26, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.63 CNY | -1.09% |
|
+0.55% | -24.53% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.53% | 382M | |
-7.33% | 83.46B | |
+33.75% | 3.95B | |
+0.70% | 3.3B | |
+21.28% | 1.77B | |
-2.34% | 1.29B | |
-38.81% | 1.01B | |
-43.09% | 949M | |
-19.59% | 839M | |
-36.06% | 834M |
- Stock Market
- Equities
- 002688 Stock
- News Jinhe Biotechnology CO., LTD.
- Tranche Update on Jinhe Biotechnology CO., LTD.'s Equity Buyback Plan announced on May 26, 2022.